General Information of Drug (ID: DMKDN1C)

Drug Name
MVA-85A Drug Info
Synonyms
AERAS-485; MVA-AG85A; MVA-85A vaccine (Mycobacterium tuberculosis infection), Oxford-Emergent Tuberculosis Consortium/TB-VAC; MVA-Ag85A vaccine (Mycobacterium tuberculosis infection), Oxford-Emergent Tuberculosis Consortium/TB-VAC
Indication
Disease Entry ICD 11 Status REF
Mycobacterium infection 1B10-1B21 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMKDN1C

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Mycobacterium Antigen complex 85A (MycB fbpA) TTZYJ8U A85A_MYCTU Not Available [2]

References

1 ClinicalTrials.gov (NCT01650389) Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination. U.S. National Institutes of Health.
2 MVA-85A, a novel candidate booster vaccine for the prevention of tuberculosis in children and adults. Curr Opin Mol Ther. 2010 Feb;12(1):124-34.